Pierre Fabre Laboratories receive positive CHMP opinion for OBGEMSA™(vibegron) in overactive bladder syndrome
CASTRES, France, April 26, 2024 /PRNewswire/ — Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP)
Read More